Pulmonary rheumatoid nodules can resemble cancer or infection, making biopsy and careful imaging critical for accurate ...

RA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA ...

Rheumatoid arthritis can pain, fatigue, and stiffness. It’s important to communicate how you’re doing to loved ones as RA can be an invisible disease in early stages. Exercise can help with ...

Joints, heart tissues, and bones are some of the main targets of inflammation-driven damage possible if you have rheumatoid arthritis While medications can help manage RA, they may also lead to ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.

MSD told Reuters that it will launch subcutaneous Keytruda in the US almost immediately after approval, if it is forthcoming, and expects that the new version could eventually account for 30% to ...

The heterogenous nature of rheumatoid arthritis renders the prediction of responsiveness to biological treatments difficult. Here the authors analyze bulk RNA-seq data from the STRAP trial (n ...

Rheumatoid arthritis affects everyone differently, but pain, inflammation, and stiffness often occur in several particular joints. Here’s what you can do to treat them.

Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

Background Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid arthritis (RA).

Objective Excess cholesterol loading on arterial macrophages is linked to foam cell formation, atherosclerosis and cardiovascular risk in rheumatoid arthritis (RA). However, the effect of changes in ...